Advance Search
LI Feng, GUO Li, CAI Liqun. Impacts of Yiqi Yangyin Tongluo Recipe combinedwith calcium dobesilate in patients with diabetes nephropathy differentiated as Qi and Yin deficiency and blood stasis syndrome[J]. Journal of Clinical Medicine in Practice, 2023, 27(15): 40-44. DOI: 10.7619/jcmp.20231206
Citation: LI Feng, GUO Li, CAI Liqun. Impacts of Yiqi Yangyin Tongluo Recipe combinedwith calcium dobesilate in patients with diabetes nephropathy differentiated as Qi and Yin deficiency and blood stasis syndrome[J]. Journal of Clinical Medicine in Practice, 2023, 27(15): 40-44. DOI: 10.7619/jcmp.20231206
shu

Impacts of Yiqi Yangyin Tongluo Recipe combinedwith calcium dobesilate in patients with diabetes nephropathy differentiated as Qi and Yin deficiency and blood stasis syndrome

  • 1.

    Department of Endocrinology, Heilongjiang Academy of Chinese Medicine, Harbin, Heilongjiang, 150040

  • 2.

    Department of Laboratory Medicine, Heilongjiang Academy of Chinese Medicine, Harbin, Heilongjiang, 150040

More Information
  • Received Date: April 16, 2023
  • Revised Date: June 11, 2023
  • Available Online: September 03, 2023
    Graphical Abstract
    • Abstract
  • Objective 

    To explore effect of Yiqi Yangyin Tongluo Recipe combined with calcium dobesilate in patients with diabetes nephropathy differentiated as Qi and Yin deficiency and blood stasis syndrome.

    Methods 

    A total of 120 patients with diabetes nephropathy (Qi and Yin deficiency and blood stasis syndrome) were selected as research objects. They were randomly divided into control group (60 cases) and observation group (60 cases). The control group was treated with calcium dobesilate, and the observation group was treated with Yiqi Yangyin Tongluo Recipe combined with calcium dobesilate. Fasting blood glucose (FBG) and 2 h postprandial blood glucose (2 h PGB) levels of two groups were compared before and after treatment. The levels of total cholesterol (TC) and triglyceride (TG) before and after treatment were measured by automatic biochemical analyzer. The levels of blood urea nitrogen (BUN) and serum creatinine (Scr) were measured by immunoturbidimetry. The 24 h urine was collected before and after treatment, and the 24 h urine protein (24 h Upro) level was detected by picric acid method. Serum levels of vascular endothelial growth factor (VEGF), endothelin (ET-1) and nitric oxide (NO) were detected by ELISA kit.

    Results 

    The total effective rate of treatment in the observation group was obviously higher than that in the control group (91.67% versus 70.00%, P < 0.05). After treatment, FBG, 2 h PGB, TC, TG, BUN, Scr, 24 h Upro levels in both groups decreased obviously compared to those before treatment, and the observation group decreased more obviously than those in the control group (P < 0.05); after treatment, the levels of creatinine clearance (Ccr) was obviously increased compared to those before treatment, and the observation group increased more obviously than those in the control group (P < 0.05). The level of hemorheology indexes in both groups decreased after treatment, and the observation group decreased more obviously than that in control group (P < 0.05).The level of ET-1 in two groups after treatment was lower than that before treatment, and the observation group decreased more obviously than that in control group (P < 0.05). The levels of VEGF and NO in two groups were higher after treatment than before treatment, and the observation group increased more obviously than those in the control group (P < 0.05).

    Conclusion 

    Yiqi Yangyin Tongluo Recipe combined with calcium dobesilate can effectively regulate glucose and lipid metabolism, improve renal function, hemorheology and vascular endothelial function in the treatment of diabetes nephropathy.

    • FullText(HTML)
    • References (20)
  • [1]
    COLE J B, FLOREZ J C. Genetics of diabetes mellitus and diabetes complications[J]. Nat Rev Nephrol, 2020, 16(7): 377-390. doi: 10.1038/s41581-020-0278-5
    [2]
    BONNER R, ALBAJRAMI O, HUDSPETH J, et al. Diabetic kidney disease[J]. Prim Care, 2020, 47(4): 645-659. doi: 10.1016/j.pop.2020.08.004
    [3]
    A/L B VASANTH RAO V R, TAN S H, CANDASAMY M, et al. Diabetic nephropathy: an update on pathogenesis and drug development[J]. Diabetes Metab Syndr, 2019, 13(1): 754-762. doi: 10.1016/j.dsx.2018.11.054
    [4]
    QIN L L, QIN W J, WANG J F, et al. Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate[J]. Exp Ther Med, 2017, 14(5): 5012-5016.
    [5]
    李金鑫, 齐记, 倪珊珊. 养阴通络汤治疗糖尿病肾病Ⅳ期临床疗效及对患者非杓型血压的影响[J]. 现代中西医结合杂志, 2023, 32(5): 657-661. doi: 10.3969/j.issn.1008-8849.2023.05.014
    [6]
    SELBY N M, TAAL M W. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines[J]. Diabetes Obes Metab, 2020, 22(Suppl 1): 3-15.
    [7]
    梁茂新, 高天舒. 《中药新药临床研究指导原则》脏腑诸证考察与分析[J]. 中国中医基础医学杂志, 2008, 14(5): 330-331, 342. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC200805004.htm
    [8]
    LEE J Y, YANG J W, HAN B G, et al. Adiponectin for the treatment of diabetic nephropathy[J]. Korean J Intern Med, 2019, 34(3): 480-491. doi: 10.3904/kjim.2019.109
    [9]
    KEATING S T, VAN DIEPEN J A, RIKSEN N P, et al. Epigenetics in diabetic nephropathy, immunity and metabolism[J]. Diabetologia, 2018, 61(1): 6-20. doi: 10.1007/s00125-017-4490-1
    [10]
    UMANATH K, LEWIS J B. Update on diabetic nephropathy: core curriculum 2018[J]. Am J Kidney Dis, 2018, 71(6): 884-895. doi: 10.1053/j.ajkd.2017.10.026
    [11]
    ZHOU Y J, QI C J, LI S, et al. Diabetic nephropathy can be treated with calcium dobesilate by alleviating the chronic inflammatory state and improving endothelial cell function[J]. Cell Physiol Biochem, 2018, 51(3): 1119-1133. doi: 10.1159/000495491
    [12]
    HAKIMIZADEH E, ZAMANIAN M Y, DAMANKHORSHID M, et al. Calcium dobesilate protects against d-galactose-induced hepatic and renal dysfunction, oxidative stress, and pathological damage[J]. Fundamemntal Clinical Pharma, 2022, 36(4): 721-730. doi: 10.1111/fcp.12766
    [13]
    LI G J, AI B C, ZHANG W H, et al. Efficacy and safety of astragalus injection combined with Western medicine in the treatment of early diabetic nephropathy[J]. Medicine, 2021, 100(12): e25096. doi: 10.1097/MD.0000000000025096
    [14]
    张家刚. 益气养阴通络汤联合前列地尔治疗糖尿病肾病临床疗效观察[J]. 实用糖尿病杂志, 2020, 16(6): 72-73. https://www.cnki.com.cn/Article/CJFDTOTAL-LNSY202006077.htm
    [15]
    李康玲, 陈光影, 韦志杰. 益气养阴通络方联合替米沙坦治疗早期2型糖尿病肾病临床疗效观察[J]. 黑龙江医药, 2020, 33(3): 587-589. https://www.cnki.com.cn/Article/CJFDTOTAL-HJYY202003047.htm
    [16]
    王庆美, 张林, 孔素梅, 等. 羟苯磺酸钙联合前列地尔对早期糖尿病肾病患者血管内皮功能的影响[J]. 海南医学院学报, 2019, 25(9): 674-678, 682. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYY201909010.htm
    [17]
    苏敏. 降糖精颗粒联合西药治疗早期糖尿病肾病的效果评价[J]. 实用临床医药杂志, 2018, 22(21): 115-117. doi: 10.7619/jcmp.201821036
    [18]
    袁博寒, 陈洪宇, 郑峰. 益气养阴通络方联合祛风湿法治疗糖尿病肾病疗效观察[J]. 中国中西医结合肾病杂志, 2020, 21(12): 1051-1054. https://www.cnki.com.cn/Article/CJFDTOTAL-JXSB202012008.htm
    [19]
    唐晨拳, 周恩超. 益气养阴通络方治疗糖尿病肾病Ⅲ~Ⅳ期气阴两虚血瘀证患者的疗效观察[J]. 实用临床医药杂志, 2021, 25(5): 79-82. doi: 10.7619/jcmp.20201463
    [20]
    刘迎迎, 郭兆安, 周太荣, 等. 益气养阴通络汤治疗糖尿病肾病G3aA2期气阴两虚血瘀证的临床疗效与安全性评价[J]. 中华中医药杂志, 2021, 36(2): 1180-1184. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202102151.htm
    • Related Articles

  • Related Articles

    [1]CHEN Yiliang, ZHANG Yinxu, CHE Zhongguang. Effect of intestinal microecological interventionon complications after operation and during chemotherapy in patients with colon cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 73-77. DOI: 10.7619/jcmp.20212087
    [2]MING Zhenye, LI Hongli. Application value of midwife-led partnership-based Doula delivery in the childbirth nursing of primiparas[J]. Journal of Clinical Medicine in Practice, 2019, 23(9): 112-114, 118. DOI: 10.7619/jcmp.201909032
    [3]GUO Yanyang, MA Jing. Effect of different body positions on operation efficacy and complications of thyroid tumor patients[J]. Journal of Clinical Medicine in Practice, 2016, (18): 98-100. DOI: 10.7619/jcmp.201618032
    [4]ZHANG Fang, YU Lijun, ZHAO Rui, LI Na, LIU Ting. Application effect of PDCA in reducing complication incidence of colorectal cancer patients with colostomy[J]. Journal of Clinical Medicine in Practice, 2016, (12): 82-84. DOI: 10.7619/jcmp.201612026
    [5]WANG Wenyan. Influence of evidence-based nursing on complications of gynecological patients in ICU[J]. Journal of Clinical Medicine in Practice, 2015, (22): 91-93. DOI: 10.7619/jcmp.201522030
    [6]JIN Chunyan. The influence of grading nursing on postpartum complications of primipara and nursing satisfaction[J]. Journal of Clinical Medicine in Practice, 2014, (20): 96-98. DOI: 10.7619/jcmp.201420030
    [7]LI Fang. The influence of nursing intervention on postoperative complications in patients with hepatolobectomy[J]. Journal of Clinical Medicine in Practice, 2014, (8): 58-60. DOI: 10.7619/jcmp.201408019
    [8]WU Xiaoli, WANG Fang, JI Jianhong. Influence of gastric lavage monitoring system for detecting liquid input-output balance on complications of gastric lavage[J]. Journal of Clinical Medicine in Practice, 2013, (20): 85-87. DOI: 10.7619/jcmp.201320029
    [9]CHEN Hongling, XU Lihua. Observation on efficacy of whole range Doula delivery combined with labor analgesia in process of spontaneous delivery[J]. Journal of Clinical Medicine in Practice, 2013, (12): 112-114. DOI: 10.7619/jcmp.201312042
    [10]CHEN Zhibing, JIANG Meiling, ZHANG Weiwen. Analysis of 300 cases of doula accompany delivery[J]. Journal of Clinical Medicine in Practice, 2012, (20): 79-80.

  • Cited by

    Periodical cited type(44)

    1. 李芳芳，范淑丽，曾海霞. 产前正念减压疗法联合心理干预对初产妇分娩结局的影响. 中国妇幼保健. 2025(02): 205-209 .
    2. 邹海平，曹明霞. 积极心理暗示联合伙伴式导乐陪伴护理在初产妇阴道分娩助产护理中的应用效果. 妇儿健康导刊. 2025(03): 136-140 .
    3. 周维娜，冯张霞，王玲玲，吴丰乐，王晓婷. 导乐陪伴联合分娩镇痛的效果及对初产妇产程进展、自然分娩率影响. 中国计划生育学杂志. 2024(01): 124-127 .
    4. 宋美勤. 导乐陪伴联合导乐分娩镇痛仪在阴道分娩初产妇中的应用效果. 妇儿健康导刊. 2024(04): 177-180 .
    5. 李季. 助产士导乐陪伴分娩护理在自然分娩初产妇中的应用效果. 中国民康医学. 2024(05): 183-186 .
    6. 杜玉绘. 助产士主导伙伴式导乐陪伴对初产妇分娩方式及产程的影响. 妇儿健康导刊. 2024(10): 152-155 .
    7. 余晨，官清清，陈钰. 探究温柔分娩理念联合会阴无创无保护接生技术对初产妇产后睡眠的影响. 世界睡眠医学杂志. 2024(04): 799-802 .
    8. 苏玲，赵海艳，郝锦绣，刘菲，尚芯羽. 转变助产服务模式下瑜伽球训练联合拉玛泽呼吸减痛法在初产妇自然分娩中的应用. 保健医学研究与实践. 2024(03): 112-116 .
    9. 孙薇，万丽. 剖宫产全程一对一导乐陪伴对产妇情绪、疼痛及新生儿状态的影响. 中国计划生育学杂志. 2024(07): 1703-1706 .
    10. 万叶. 家庭式温馨干预环境联合导乐分娩对初产妇产程、分娩结局及疼痛的影响. 吉林医学. 2024(08): 2006-2009 .
    11. 乐翠华，柳娜，吴文娟. 导乐陪伴分娩联合镇痛分娩对产程及分娩结局的影响. 医学信息. 2024(16): 165-168 .
    12. 李红梅，赖志萍，曾丽玲. 导乐陪伴助产联合人本关怀对妊娠期高血压产妇产程和分娩结局的影响. 基层医学论坛. 2024(27): 76-79 .
    13. 刘红丽，孔颖. 一对一全程陪伴助产模式对高龄初产妇不适感及心理应激的临床效果. 河北医药. 2024(18): 2877-2880 .
    14. 魏婉，李艳丽，李雪敏. 气囊仿生无创助产在缩短阴道分娩初产妇产程及减轻机体免疫抑制方面的作用及其对盆底肌力恢复的影响. 航空航天医学杂志. 2024(10): 1234-1236 .
    15. 夏瑀. 一对一导乐陪伴联合自由体位用于初产妇自然分娩中的效果. 航空航天医学杂志. 2024(11): 1396-1399 .
    16. 李芳. 助产士一对一导乐陪伴分娩对初产妇心理状态及分娩指标的影响. 实用中西医结合临床. 2023(02): 121-124 .
    17. 张静，吕国栋. 产前减压辅助盐酸罗哌卡因硬膜外注射在减轻高龄孕产妇分娩疼痛中的应用. 河北医药. 2023(22): 3460-3462+3466 .
    18. 楚慧. 导乐分娩镇痛仪联合导乐陪伴护理在阴道试产初产妇中的应用. 妇儿健康导刊. 2023(15): 173-175 .
    19. 李萍. 助产护理与人文关怀联用对高龄初产妇分娩方式及负性心理情绪的影响. 中华养生保健. 2023(19): 167-169 .
    20. 徐晓娟. 产房分娩实施人文关怀结合体位护理的效果分析. 实用妇科内分泌电子杂志. 2023(27): 135-137 .
    21. 尤金兰，钱秀君. 仿真分娩模拟课堂应用于初产妇中对分娩结局及分娩体验的影响. 国际护理学杂志. 2022(02): 370-372 .
    22. 纪小花，郝坍. 导乐陪伴分娩对初产妇产程时间及生活质量的影响. 中国卫生标准管理. 2022(05): 154-157 .
    23. 李彩凤，陈慧超. 导乐球联合自由体位用于初产妇分娩过程中的护理干预效果. 中国现代医生. 2022(07): 182-184+188 .
    24. 刘元兰. 穴位按摩联合导乐分娩在初产妇分娩中的应用效果. 现代养生. 2022(09): 696-698 .
    25. 黄贤好. 体位管理联合全程陪伴式导乐分娩对初产妇产程时间及分娩结局的影响. 黑龙江医药. 2022(03): 730-733 .
    26. 刘浩伟. 导乐治疗仪在经产妇分娩中的应用效果. 中国城乡企业卫生. 2022(06): 93-95 .
    27. 徐珊. 导乐分娩联合无痛分娩效果观察及对妊娠结局的影响. 中国基层医药. 2022(06): 820-824 .
    28. 袁逸菁，王祥雯，范颖. 系统化管理方案在阴道分娩初产妇产后会阴疼痛和损伤中的应用效果. 国际护理学杂志. 2022(14): 2611-2614 .
    29. 徐其艳. 导乐分娩镇痛仪联合剖宫产术后再次妊娠阴道试产产程监测及分娩指导在产妇分娩中的应用效果. 医疗装备. 2022(16): 134-136 .
    30. 张丽芳. 产妇给予导乐分娩联合家庭式温馨护理的效果及对情绪、分娩结局及新生儿的影响. 数理医药学杂志. 2022(12): 1837-1839 .
    31. 蔺雅菲. 导乐镇痛仪联合舒适护理在阴道分娩产妇中的应用效果. 医疗装备. 2022(20): 134-136 .
    32. 许淑仪，苏杰，郑迅风，董巨浪. 罗哌卡因联合芬太尼连续硬膜外麻醉用于无痛分娩中对母婴的影响. 名医. 2022(20): 90-92 .
    33. 梁依斐，黄芳. 导乐陪伴分娩联合椎管内分娩镇痛的效果及对妊娠结局的影响. 中国医药科学. 2021(06): 87-89+107 .
    34. 陈晓丽，陈琼，方洁，陈果. 罗哌卡因联合舒芬太尼自控镇痛泵对高龄孕妇无痛分娩疼痛强度及分娩结局的作用. 中国妇幼保健. 2021(10): 2404-2406 .
    35. 李壮丽. 导乐联合硬膜外分娩镇痛对初产妇镇痛效果及分娩方式的影响. 现代诊断与治疗. 2021(12): 1959-1961 .
    36. 王爱琴，彭雪琴，张静，严婷. 瑜伽指导联合导乐陪伴待产对初产妇产程进展、焦虑情绪及分娩质量的影响. 循证护理. 2021(08): 1094-1097 .
    37. 宋静. 导乐分娩在经阴道分娩高龄产妇中的应用效果. 中国民康医学. 2021(14): 181-182 .
    38. 许春燕，倪冬梅，李琼珊. 高龄初产妇不良心理情绪的影响因素分析. 中国妇幼健康研究. 2021(08): 1144-1147 .
    39. 张静，高丽娟，金环. 一对一导乐陪伴联合非药物分娩镇痛在自然分娩产妇中的应用. 齐鲁护理杂志. 2021(18): 139-141 .
    40. 张小凤，吴艳玲，刘凤琴. 导乐仪分娩镇痛结合自由体位助产法干预对初产妇分娩自控感及自我效能感的影响. 临床医学研究与实践. 2021(29): 193-195 .
    41. 沈端平，唐秋霞. 斜挎式固定装置用于便携式导乐仪对产妇分娩镇痛效果、舒适度及不良情绪的影响. 中国当代医药. 2021(33): 126-128 .
    42. 陈美莺，黄丽娟. 导乐陪伴联合自控式硬膜外分娩镇痛对产妇分娩疼痛和分娩质量的影响. 中西医结合护理(中英文). 2021(04): 88-90 .
    43. 王新娟. 激励式心理护理结合导乐陪伴对初产妇自然分娩率和情绪状态的影响. 中西医结合护理(中英文). 2021(05): 85-87 .
    44. 黄相珂. 导乐陪伴分娩促进初产妇阴道自然分娩及降低剖宫产率的护理作用观察. 临床研究. 2020(11): 144-145 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (142) PDF downloads (8) Cited by(44)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return